Composition of Optomed’s Nomination Board
Optomed Plc Stock Exchange Release 11 September 2020 at 12.00, Helsinki Composition of Optomed’s Nomination Board According to Optomed’s shareholder register of 1 September 2020, the shareholders represented in the shareholders’ Nomination Board are Cenova Capital’s controlled entities (Alnair Investments, Cenova China Healthcare Fund IV and Shanghai Cenova Innovation Venture Fund (Limited Partnership)), Robert Bosch Venture Capital GmbH and Aura Capital Oy. These shareholders have appointed the following persons to the Nomination Board: · Hai Wu, Cenova Capital ·